COX-2 inhibitors and risk of heart failure

被引:7
|
作者
Kammerl, MC [1 ]
Debler, J [1 ]
Riegger, GA [1 ]
Krämer, BK [1 ]
机构
[1] Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany
来源
LANCET | 2004年 / 364卷 / 9444期
关键词
D O I
10.1016/S0140-6736(04)17265-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1486 / 1487
页数:2
相关论文
共 50 条
  • [21] COX-2 inhibitors associated with varying risk of MI
    不详
    FORMULARY, 2005, 40 (01) : 12 - 12
  • [22] Risk of hyperkalemia associated with selective COX-2 inhibitors
    Aljadhey, Hisham
    Tu, Wanzhu
    Hansen, Richard A.
    Blalock, Susan
    Brater, Craig
    Murray, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1194 - 1198
  • [24] COX-2 inhibitors and cardiovascular risk - Point and counterpoint
    Mandell, BF
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (11) : 957 - 960
  • [25] Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
    Perry, Laura A.
    Mosier, Charles
    Atkins, Ashton
    Minehart, Megan
    US PHARMACIST, 2014, 39 (03) : 35 - 38
  • [26] Are COX-2 inhibitors a risk factor for cardiovascular disease?
    John, S
    Schmieder, RE
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (04) : 156 - 159
  • [27] Selective COX-2 inhibitors and risk of myocardial infarction
    Krötz, F
    Schiele, TM
    Klauss, V
    Sohn, HY
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 (04) : 312 - 324
  • [28] Rofecoxib, selective COX-2 inhibitors and cardiovascular risk
    Dhaun, N.
    Maxwell, S. R. J.
    Webb, D. J.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2005, 35 (02): : 101 - 103
  • [29] COX-2 inhibitors and renal failure: the triple whammy revisited
    Boyd, IW
    Mathew, TH
    Thomas, MC
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (05) : 274 - 274
  • [30] COX-2 inhibitors and early failure of free vascular flaps
    Al-Sukhun, Jehad
    Koivusalo, Anu
    Tornwall, Jyrki
    Lindqvist, Christian
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (05): : 528 - 529